SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
University of Cambridge · Addenbrooke's Hospital · +3 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
358
total citations
- FWCI
- 32.76
- Percentile
- 100%
- References
- 87
Citations per year
Authors
11- MCMacGregor CoxCorresponding
University of Cambridge, Addenbrooke's Hospital
- TPThomas P. Peacock
St Mary's Hospital, Imperial College London
- WTWilliam T. Harvey
MRC University of Glasgow Centre for Virus Research
- JHJoseph Hughes
MRC University of Glasgow Centre for Virus Research
- DWDerek Wright
MRC University of Glasgow Centre for Virus Research
Topics & keywords
Topics
Keywords
- Neutralization
- Monoclonal antibody
- Epitope
- Virology
- Biology
- Antibody
- Evasion (ethics)
- In vitro
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- URUK Research and InnovationAwards: MR/W005611/1, MC_PC_19027
- NINational Institute for Health and Care ResearchAward: MC_PC_19027
- DODepartment of Health and Social CareAward: COVID-19 Genomics Programme
- MRMedical Research CouncilAwards: MC_PC_19027, MC_UU_12014, MC_PC_19026, MC_UU_00034/6, MR/W005611/1, MC_UU_12014/12, COVID-19
- BABiotechnology and Biological Sciences Research CouncilAward: BB/R019843/1